A bifunctional hybrid molecule of the amino-terminal fragment of urokinase and domain II of bikunin efficiently inhibits tumor cell invasion and metastasis

European Journal of Biochemistry

Volumn 253, Issue 3, 1998, Pages 817-826

  Kobayashi, Hiroshi ^a,c   Sugino, Dan ^b   She, Ming Yu ^a   Ohi, Hidekazu ^a   Hirashima, Yasuyuki ^a   Shinohara, Hiromitsu ^a   Fujie, Michio ^c   Shibata, Kiyoshi ^c   Terao, Toshihiko ^a  

^a HAMAMATSU UNIVERSITY   (Japan)

^b Nissin Central Research Institute   (Japan)

^c HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Amino terminal fragment; Bikunin; Hybrid protein; Urinary trypsin inhibitor; Urokinase type plasminogen activator

Indexed keywords

MATRIGEL; ULINASTATIN; UROKINASE;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; CELL INVASION; DNA SEQUENCE; ENZYME STRUCTURE; ESCHERICHIA COLI; GENETIC ENGINEERING; METASTASIS INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN;

ESCHERICHIA COLI; NEGIBACTERIA;

EID: 0032079489     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.1998.2530817.x     Document Type: Article

References (52)

1. Dano, K., Andreasen, P. A., Grondahl-Hansen, J., Kristensen, P. I., Nielsen, L. S. & Skriver, L. (1985) Plasminogen activators, tissue degradation, and cancer, Adv. Cancer Res. 44, 139-266.
2. Stoppelli, M. P., Tacchetti, C., Cubellis, M. V. Corti, A., Hearing, V. J., Cassani, G., Appella, E. & Blasi, F. (1996) Autocrine saturation of pro-urokinase receptors on human A431 cells, Cell 45, 675-684.
3. Appella, E., Robinson, E. A., Ullrich, S. J., Stoppelli, M. P., Corti, A., Cassani, G. & Blasi, F. (1987) The receptor-binding sequence of urokinase. A biological function for the growth-factor module of proteases, J. Biol. Chem. 262, 4437-4440.
4. r 55 000 form of the human plasminogen activator, urokinase, J. Cell Biol. 100, 86-92.
5. Sitrin, R. G., Todd, R. F. III, Mizukami, I. F, Gross, T. J., Shollenberger, S. B. & Gyetko, M. R. (1994) Cytokine-specific regulation of urokinase receptor (CD87) expression by U937 mononuclear phagocytes, Blood 84, 1268-1275.
6. Vassalli, J.-D., Wohlwend, A. & Belin, D. (1992) Urokinase-catalyzed plasminogen activation at the monocyte/macrrophage cell surface: a localized and regulated proteolytic system, Curr. Top. Microbiol. Immunol. 181, 65-86.
7. Kirchheimer, J. C. & Remold, H. G. (1989) Functional characteristics of receptor-bound urokinase on human monocytes: catalytic efficiency and susceptibility to inactivation by plasminogen activator inhibitors, Blood 74, 1396-1402.
8. Kirchheimer, J. C. & Remold, H. G. (1989) Endogenous receptor-bound urokinase mediates tissue invasion of human monocytes, J. Immunol. 143, 2634-2639.
9. Ploug, M., Rønne, E., Behrend, N., Jensen, A. L., Blasi, F & Dano, K. (1991) Cellular receptor for urokinase plasminogen activator: carboxyl-terminal processing and membrane anchoring by glycosylphosphatidylinositol, J. Biol. Chem. 266, 1926-1933.
10. Behrendt, N., Ronne, E. & Dano, K. (1995) The structure and function of the urokinase receptor, a membrane protein govering plasminogen activation on the cell surface, Biol. Chem. Hoppe-Seyler 376, 269-279.
11. Crowley, C. W., Cohen, R. L., Lucas, B. K., Liu, G., Shuman, M. A. & Levinson, A. D. (1993) Prevention of metastasis by inhibition of the urokinase receptor, Proc. Natl Acad. Sci. USA 90, 5021-5025.
12. Schmitt, M., Wilhelm, O., Janicke, F., Magdolen, V., Reuning, U., Ohi, H., Moniwa, N., Kobayashi, H., Weidle, U. & Graeff, H. (1995) Urokinase-type plasminogen activator (uPA) and its receptor (CD87): a new target in tumor invasion and metastasis, J. Obstet. Gynecol. 21, 151-165.
13. Kobayashi, H., Ohi, H., Shinohara, H., Sugimura, M., Fujii, T., Terao, T., Schmitt, M., Goretzki, L., Chucholowski, N., Jänicke, F. & Graeff, H. (1993) Saturation of tumour cell surface receptors for urokinase-type plasminogen activator by amino-terminal fragment and subsequent effect on reconstituted basement membranes invasion, Br. J. Cancer 67, 537-544.
14. Kobayashi, H., Gotoh, J., Fujie, M., Shinohara, H., Moniwa, N. & Terao, T. (1994) Inhibition of metastasis of Lewis lung carcinoma by a synthetic peptide within growth factor-like domain of urokinase in the experimental and spontaneous metastasis model, Int. J. Cancer 57, 727-733.
15. Wilhelm, O., Werdle, U., Hohl, S., Rettenberger, P., Schmitt, M. & Graeff, H. (1994) Recombinant soluble urokinase receptor as a scavenger for urokinase-type plasminogen activator (uPA). Inhibition of proliferation and invasion of human ovarian cancer cells, FEBS Lett. 337, 131-134.
16. Kobayashi, H., Fujie, M., Shinohara, H., Ohi, H., Sugimura, M. & Terao, T. (1994) Effects of urinary trypsin inhibitor on the invasion of reconstituted basement membranes by ovarian cancer cells, Int. J. Cancer 57, 378-384.
17. Kobayashi, H., Shinohara, H., Takeuchi, K., Itoh, M., Fujie, M., Saitoh, M. & Terao, T. (1994) Inhibition of the soluble and the tumor cell receptor-bound plasmin by urinary trypsin inhibitor and subsequent effects on tumor cell invasion and metastasis, Cancer Res. 54, 844-849.
18. Kobayashi, H., Shinohara, H., Ohi, H., Sugimura, M. Terao, T. & Fujie, M (1994) Urinary trypsin inhibitor (UTI) and fragments derived from UTI by limited proteolysis efficiently inhibit tumor cell invasion, Clin. Exp. Metastasis 12, 117-128.
19. Kobayashi, H., Shinohara, H., Gotoh, J., Fujie, M., Fujishiro, S. & Terao, T. (1995) Anti-metastatic therapy by urinary trypsin inhibitor in combination with an anti-cancer agent, Br. J. Cancer 72, 1131-1137.
20. Kobayashi, H., Gotoh, J., Hirashima, Y., Fujie, M., Sugino, D. & Terao, T. (1995) Inhibitory effect of a conjugate between human urokinase and urinary trypsin inhibitor on tumor cell invasion in vitro, J. Biol. Chem. 270, 8361-8366.
21. Kobayashi, H., Gotoh, J., Kanayama, N., Hirashima, Y., Terao, T. & Sugino, D. (1995) Inhibition of tumor cell invasion through Matrigel by a peptide derived from the domain II region in urinary trypsin inhibitor, Cancer Res. 55, 1847-1852.
22. Kobayashi, H., Gotoh, J., Shinohara, H., Moniwa, N. & Terao, T. (1994) Inhibition of the metastasis of Lewis lung carcinoma by antibody against urokinase-type plasminogen activator in the experimental and spontaneous metastasis model, Thromb. Haemost. 71, 474-480.
23. Kobayashi, H., Gotoh, J., Hirashima, Y. & Terao, T. (1996) Expression of urokinase and urinary trypsin inhibitor in metastatic and non-metastatic murine Lewis lung carcinoma cells, Int. J. Oncol. 8, 757-763.
24. Hollas, W., Blasi, F. & Boyd, D. (1991) Role of the urokinase receptor in facilitating extracellular matrix invasion by cultured colon cancer, Cancer Res. 51, 3690-3695.
25. Guesdon, J. L., Ternynck, T. & Avrameas, S. (1979) The use of avidin-biotin interaction in immunoenzymatic techniques, J. Histochem. Cytochem. 27, 1131-1139.
26. Kobayashi, H., Schmitt, M., Goretzki, L., Chucholowski, N., Calvete, J., Kramer, M., Günzler, W. A., Jänicke, F. & Graeff, H. (1991) Cathepsin B efficiently activates the soluble and the tumor cell receptor-bound form of the proenzyme urokinase-type plasminogen activator (pro-uPA), J. Biol. Chem. 266, 5147-5152.
27. Kobayashi, H., Moniwa, N., Sugimura, M., Shinohara, H., Ohi, H. & Terao, T. (1993) Effects of membrane-associated cathepsin B on the activation of receptor-bound prourokinase and subsequent invasion of reconstituted basement membranes, Biochim. Biophys. Acta 1178, 55-62.
28. Puri, R. K., Leland, P., Kreitman, R. J. & Pastan, I. (1994) Human neurological cancer cells express interleukin-4 (IL-4) receptors which are targets for the toxic effects of IL4-pseudomonas exotoxin chimeric protein, Int. J. Cancer 58, 574-581.
29. Kariko, K., Kuo, A., Boyd, D., Okada, S. S., Cines, D. B. & Barnathan, E. S. (1993) Overexpression of urokinase receptor increases matrix invasion without altering cell migration in a human osteosarcoma cell line, Cancer Res. 53, 3109-3117.
30. Hochstrasser, K., Schonberger, O. L., Rossmanith, I. & Wachter, E. (1981) Kunitz-type protease inhibitors derived by limited proteolysis of inter-α-trypsin inhibitor, V, Hoppe-Seyler Z. Physiol. Chem. 362, 1357-1362.
31. Wachter, E. & Hochstrasser, K. (1981) Kunitz-type protease inhibitors derived by limited proteolysis of the inter-alpha-trypsin inhibitor, IV, Hoppe-Seyler's Z. Physiol. Chem. 362, 1351-1355.
32. Albrecht, G. J., Hochstraser, K. & Salier, J.-P. (1983) Kunitz-type protease inhibitors derived by limited proteolysis of the inter-alpha-trypsin inhibitor, IX, Hoppe-Seyler's Z. Physiol. Chem. 364, 1703-1708.
33. Reisinger, P., Hochstrasser, K., Albrecht, G. J., Lempart, K. & Salier, J.-P. (1985) Human inter-alpha-trypsin inhibitor: localization of the Kunitz-type domains in the N-terminal part of the molecule and their release by a trypsin-like proteinases, Biol. Chem. Hoppe-Seyler 366, 479-483.
34. Balduyck, M., Laroui, S., Mizon, C. & Mizon, J. A. (1989) A proteoglycan related to the urinary teypsin inhibitor (UTI) links the two heavy chains of inter-alpha-trypsin inhibitor, Biol. Chem. Hoppe-Seyler 370, 329-336.
35. Hochstrasser, K., Albrecht, G. J., Schonberger, O. L. & Wachter, E. (1989) Kunitz-type protease inhibitors derived by limited proteolysis of the inter-alpha-trypsin inhibitor, VIII, Hoppe-Seyler's Z., Physiol. Chem. 370, 1689-1696.
36. Kobayashi, H., Gotoh, J., Fujie, M. & Terao, T. (1994) Characterization of the cellular binding site for the urinary trypsin inhibitor, J. Biol. Chem. 269, 20642-20647.
37. Kobayashi, H. Gotoh, J., Hirashima, Y. & Terao, T. (1996) Inter-α-trypsin inhibitor bound to tumor cells is cleaved into the heavy chains and the light chain on the cell surface, J. Biol. Chem. 271, 11 362-11 367.
38. Ballance, D. J., Marshall, J. M., Cottingham, I. R., Steven, J., Berry, S., Cederholm-Williams, S. A., Goodey, A. R. & Courtney, M. (1992) A hybrid protein of urokinase growth-factor domain and plasminogen activator inhibitor type 2 inhibits urokinase activity and hinds to the urokinase receptor, Eur. J. Biochem. 207, 177-183.
39. Cavallaro, U., delVecchio, A., Lappi, D. A. & Soria, M. R. (1943) A conjugate between human urokinase and saporin, a type-1 ribosome-inactivating protein, is selectively cytotoxic to urokinase receptor-expressing cells, J. Biol Chem. 268, 23 186-23 190.
40. Xiang, J., Koropatnick, J., Qi, Y., Luo, X., Moyana, T., Li, K. & Chen, Y. (1993) Production of a bifunctional hybrid molecule B72.3/metallothionein-1 by protein engineering, Immunology 78, 574-581.
41. Sarosdy, M. F., Hutzler, D. H., Yee, D. & von Hoff, D. D. (1993) In vitro sensitivity of human bladder cancers and cell lines to TP-40, a hybrid protein with selective targeting and cytotoxicity, J. Urol. 150, 1950-1955.
42. Sforzini, S., Bolognesi, A., Meazza, M., Marciano, S., Casalini, P., Dürkop, H., Tazzari, P. L., Stein, H., Stirpe, F. & Ferrini, S. (1995) Differential sensitivity of CD30+ neoplastic cells to gelonin delivered by anti-CD30/anti-gelonin bispecific antibodies, Br. J. Haematol. 90, 572-577.
43. Niedbala, M. J. & Stein-Picarella, M. (1993) Role of protein kinase C in tumor necrosis factor induction of endothelial cell urokinase-type plasminogen activator, Blood 81, 2608-2607.
44. Waltz, D. A. & Chapman, H. A. (1994) Reversible cellular adhesion to vitronectin linked to urokinase receptor occupancy, J. Biol. Chem. 269, 14746-14750.
45. Olson, D., Pöllänen, J., Høyer-Hansen, G., Rønne, E., Sakaguchi, K., Wun, T.-C., Appella, E., Dano, K. & Blasi, F. (1992) Internalization of the urokinase-plasminogen activator inhibitor type-1 complex is mediated by the urokinase receptor, J. Biol. Chem. 267, 9129-9133.
46. 2-macroglobulin receptor-LDL receptor-related protein binds urokinase/plasminogen activator inhibitor type-1 complex, J. Biol. Chem. 267, 14 543-14 546.
47. Li, H., Kuo, A., Kochan, J., Strickland, D., Kariko, K., Barnathan, H. S. & Cines, D. B. (1994) Endocytosis of urokinase-plasminogen activator inhibitor type 1 complexes bound to a chimeric transmembrane urokinase receptor, J Biol. Chem. 269, 8153-8158.
48. 2-macroblobulin receptor, J. Biol. Chem. 269, 17 886-17 892.
49. 2-macroblobulin receptor/low density lipoprotein receptor-related protein, J. Biol. Chem. 269, 25 668-25 676.
50. 2-macroblobulin receptor/Ldl receptor-related protein (Lrp)-dependent internalization of the urokinase receptor, J. Cell Biol. 131, 1609-1622.
51. Rabbani, S. A., Mazar, A. P., Bernier, S. M., Haq, M., Bolivar, I., Henkin, J. & Geltzman, D. (1991) Structural requirments for the growth factor activity of the amino-terminal domain of urokinase, J. Biol. Chem. 267, 14 151-14 156.
52. Sreerama, S., Kumar, A., Johnson, A., Purblitz, S. & Idell, S. (1995) Urokinase receptor in human malignant mesothelioma cells: role in tumor cell mitogenesis and proteolysis, Am. J. Physiol. 268, L972-L982.